As a radiologist in an academic medical center, I am devoted to improving clinical care for my patients suffering from breast and prostate cancer. My research has focused on developing new imaging protocols and on correlating prostate and breast cancer imaging phenotypes and MR/US imaging classifiers with histology, immunohistochemistry, and gene expression profiles. I recognize the imperative need for correlating imaging phenotypes with tumor genotypes in order to advance knowledge regarding a broad range of breast and prostate diseases, as well as their early diagnosis, progression/behavior and treatment, by developing new (imaging) biomarkers.
A second major research focus is the design and development of biopsy and treatment tools, like biopsy markers (biopsy clips; Coulter award 2011), and treatment planning phantoms and atlases in collaboration with engineers and image post-processors.
- Chief, MR Imaging, Boston Medical Center
- Member, BU-BMC Cancer Center, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Co-Director, MS Bioimaging Program, Boston University Chobanian & Avedisian School of Medicine
- Program Director, Breast Imaging Fellowship, Boston University Chobanian & Avedisian School of Medicine
- University of Vienna, MD
- University of Vienna, BA
- Published on 6/14/2019
Chirra P, Leo P, Yim M, Bloch BN, Rastinehad AR, Purysko A, Rosen M, Madabhushi A, Viswanath SE. Multisite evaluation of radiomic feature reproducibility and discriminability for identifying peripheral zone prostate tumors on MRI. J Med Imaging (Bellingham). 2019 Apr; 6(2):024502. PMID: 31259199.
- Published on 4/5/2019
Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmore H, Plecha D, Varadan V, Madabhushi A. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open. 2019 04 05; 2(4):e192561. PMID: 31002322.
- Published on 2/28/2019
Viswanath SE, Chirra PV, Yim MC, Rofsky NM, Purysko AS, Rosen MA, Bloch BN, Madabhushi A. Comparing radiomic classifiers and classifier ensembles for detection of peripheral zone prostate tumors on T2-weighted MRI: a multi-site study. BMC Med Imaging. 2019 02 28; 19(1):22. PMID: 30819131.
- Published on 8/6/2018
Lee CL, Dietrich MC, Desai UG, Das A, Yu S, Xiang HF, Jaffe CC, Hirsch AE, Bloch BN. A 3D-Printed Patient-Specific Phantom for External Beam Radiation Therapy of Prostate Cancer. J Eng Sci Med Diagn Ther. 2018 Nov; 1(4). PMID: 30775692.
- Published on 12/13/2017
Kan CK, Qureshi MM, Gupta A, Agarwal A, Gignac GA, Bloch BN, Thoreson N, Hirsch AE. Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital. Adv Radiat Oncol. 2018 Apr-Jun; 3(2):181-189. PMID: 29904743.
- Published on 10/1/2017
Yu H, Scalera J, Khalid M, Touret AS, Bloch N, Li B, Qureshi MM, Soto JA, Anderson SW. Texture analysis as a radiomic marker for differentiating renal tumors. Abdom Radiol (NY). 2017 Oct; 42(10):2470-2478. PMID: 28421244.
- Published on 5/19/2017
Jain A, Khalid M, Qureshi MM, Georgian-Smith D, Kaplan JA, Buch K, Grinstaff MW, Hirsch AE, Hines NL, Anderson SW, Gallagher KM, Bates DDB, Bloch BN. Stereotactic core needle breast biopsy marker migration: An analysis of factors contributing to immediate marker migration. Eur Radiol. 2017 Nov; 27(11):4797-4803. PMID: 28526892.
- Published on 4/13/2017
Xiang HF, Lu HM, Efstathiou JA, Zietman AL, De Armas R, Harris K, Bloch BN, Qureshi MM, Keohan S, Hirsch AE. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer. J Appl Clin Med Phys. 2017 05; 18(3):37-43. PMID: 28407345.
- Published on 2/18/2016
Wan T, Bloch BN, Plecha D, Thompson CL, Gilmore H, Jaffe C, Harris L, Madabhushi A. A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Sci Rep. 2016 Feb 18; 6:21394. PMID: 26887643.
- Published on 6/10/2015
Kaplan JA, Grinstaff MW, Bloch BN. Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers. Eur Radiol. 2016 Mar; 26(3):866-73. PMID: 26060064.
View 42 more publications: View full profile at BUMC